G
Guest
Guest
http://www.hairlosshelp.com/hair_clonin ... erview.cfm
-------------------------
HAIRLOSSHELP: When you start your trials in September 2004, are these limited to a specific number of people, or are these ongoing treatments/trials that will continue indefinitely?
PROF. BAZAN: At that stage (final trial, mid to full size impregnations) it will be an "Open" yet limited (in number of subjects) trial. A "limited commercial" trial, if you like. The already registered individuals can become patients if they wish. The pre-registered patients have priority, of course.
After that list is satisfied, then we will present publish the results, and we will (likely) have clearance for a full blown commercial availability. Yet, we can only do 2 patients per 7 day week. If we could have the commercial capacity of opening branches we would open more impregnation centers (while keeping one centralized matrix-culture center in Aguascalientes).
------------------------
If this works then it could be a lifeline for until stemcell treatement is possible.
-------------------------
HAIRLOSSHELP: When you start your trials in September 2004, are these limited to a specific number of people, or are these ongoing treatments/trials that will continue indefinitely?
PROF. BAZAN: At that stage (final trial, mid to full size impregnations) it will be an "Open" yet limited (in number of subjects) trial. A "limited commercial" trial, if you like. The already registered individuals can become patients if they wish. The pre-registered patients have priority, of course.
After that list is satisfied, then we will present publish the results, and we will (likely) have clearance for a full blown commercial availability. Yet, we can only do 2 patients per 7 day week. If we could have the commercial capacity of opening branches we would open more impregnation centers (while keeping one centralized matrix-culture center in Aguascalientes).
------------------------
If this works then it could be a lifeline for until stemcell treatement is possible.